Why the Respiri (ASX:RSH) share price shot 18% higher today

Ken Hall | April 28, 2021 11:07am | More on: RSH

Image source: Getty Images

The Respiri Ltd Fully Paid Ord. Shrs (ASX: RSH) share price has rocketed 18.2% higher at the market open after an update from the Aussie medical device company.

Why is the Respiri share price on the charge?

Respiri this morning announced a new agreement with TerryWhite Chemmart. The agreement will see TerryWhite Chemmart stores sell and market wheezo, commencing immediately.

wheezo is Respiri’s medical device that records breathing sounds and detects and analyses wheeze. The innovative device helps to identify and manage symptoms associated with asthma.

TerryWhite Chemmart is Australia’s largest pharmacy network with over 450 community pharmacies. The Respiri share price rocketed 18.2% at Wednesday’s open as investors reacted well to the new deal.

Respiri CEO and Managing Director, Mr Marjan Mikel, said, “Respiri continues to grow wheezo product availability in the pharmacy channel as we recognise the important role that pharmacies play with supporting asthma management and care”.

“This agreement with Terry White Chemmart takes the number of pharmacies contracted to stock and sell wheezo to approximately 1,000 stores”, he added. That represents an “implied market footprint” of 22% based on the total number of ex-hospital community pharmacies in Australia.

The Respiri share price has once again surged higher this morning on the back of the news. At the time of writing, the Aussie medical device company’s shares were up 18.2% for the day and 85.7% in the last 12 months.

Respiri said it remains in active discussions with several other large pharmacy banner groups. Further ASX announcements are expected once those discussions are finalised and initial orders have commenced.

Foolish takeaway

The Respiri share price has rocketed higher today after a new partnership announcement. The deal with TerryWhite Chemmart will expand its network of pharmacies selling the proprietary wheezo device across Australia.

That’s been enough for shareholders to snap up the Aussie healthcare share in one of the day’s early strong performers.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.